Cerberus Research LabsAmerican-run from Asia / US combat veteran owned and operated
Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide. It is studied in metabolic, incretin-signaling, and glucose-regulation research models, and is supplied strictly as a research-use-only catalog material for qualified laboratory workflows.
Research Use Only. No clinical, diagnostic, human, or veterinary use.
Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide. It is studied in metabolic, incretin-signaling, and glucose-regulation research models, and is supplied strictly as a research-use-only catalog material for qualified laboratory workflows. Any discussion of future applications is hypothetical and should not be interpreted as human or veterinary use guidance.
Research discussion focuses on pathway signaling and assay behavior in controlled laboratory models, not human outcomes or dosing.
Current literature and supplier documentation are reviewed in the context of compound identity, lot consistency, assay suitability, and controlled research workflow design.
Any future application discussion is hypothetical, non-promotional, and not clinical guidance. This listing is restricted to laboratory research-use-only review.
Reference placeholders can be added after legal and scientific review. Do not treat this catalog page as medical or regulatory advice.
COA / lot documentation available by request. Open COA image
RUO
Semaglutide is being researched for its role in GLP-1 signaling, metabolic regulation, appetite-signaling models, and glucose-related research pathways.
RUO
Retatrutide is being researched for its role in GLP-1, GIP, and glucagon signaling pathways within metabolic and body-composition research models.
RUO
Cagrilintide is being researched within metabolic research, appetite signaling, glucose regulation as a research-use-only catalog material for qualified laboratory and analytical workflows.
RUO
Semaglutide is being researched for its role in GLP-1 signaling, metabolic regulation, appetite-signaling models, and glucose-related research pathways.
